Healthcare provider profile · identity verified

James Williams

Internal Medicine · BIRMINGHAM, AL · NPI 1700999232

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	519	195
Amlodipine Besylate	Amlodipine Besylate	420	148
Gabapentin	Gabapentin	380	103
Losartan Potassium	Losartan Potassium	343	132
Levothyroxine Sodium	Levothyroxine Sodium	263	90
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	238	49
Pantoprazole Sodium	Pantoprazole Sodium	234	83
Trazodone Hcl	Trazodone Hcl	186	67
Hydrochlorothiazide	Hydrochlorothiazide	183	66
Ozempic	Semaglutide	175	32
Alprazolam	Alprazolam	172	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	167	40
Furosemide	Furosemide	159	67
Lisinopril	Lisinopril	157	64
Eliquis	Apixaban	143	45
Tramadol Hcl	Tramadol Hcl	136	34
Pravastatin Sodium	Pravastatin Sodium	130	44
Carvedilol	Carvedilol	126	50
Metformin Hcl	Metformin Hcl	125	49
Omeprazole	Omeprazole	121	47
Lorazepam	Lorazepam	119	22
Clonazepam	Clonazepam	114	28
Rosuvastatin Calcium	Rosuvastatin Calcium	114	41
Tamsulosin Hcl	Tamsulosin Hcl	109	45
Sertraline Hcl	Sertraline Hcl	107	39
Metformin Hcl Er	Metformin Hcl	99	38
Chlorthalidone	Chlorthalidone	98	40
Potassium Chloride	Potassium Chloride	98	37
Allopurinol	Allopurinol	94	33
Zolpidem Tartrate	Zolpidem Tartrate	89	23
Azithromycin	Azithromycin	83	64
Olmesartan Medoxomil	Olmesartan Medoxomil	82	33
Metoprolol Succinate	Metoprolol Succinate	81	32
Oxycodone Hcl	Oxycodone Hcl	81	13
Escitalopram Oxalate	Escitalopram Oxalate	80	38
Jardiance	Empagliflozin	79	24
Metoprolol Tartrate	Metoprolol Tartrate	77	29
Mounjaro	Tirzepatide	75	12
Meloxicam	Meloxicam	72	30
Montelukast Sodium	Montelukast Sodium	72	20
Albuterol Sulfate Hfa	Albuterol Sulfate	70	34
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	69	56
Duloxetine Hcl	Duloxetine Hcl	68	17
Fluoxetine Hcl	Fluoxetine Hcl	67	14
Fluticasone Propionate	Fluticasone Propionate	63	30
Tizanidine Hcl	Tizanidine Hcl	63	22
Spironolactone	Spironolactone	60	25
Esomeprazole Magnesium	Esomeprazole Magnesium	55	18
Simvastatin	Simvastatin	55	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	23
Atenolol	Atenolol	51	18
Citalopram Hbr	Citalopram Hydrobromide	48	18
Clopidogrel	Clopidogrel Bisulfate	48	19
Donepezil Hcl	Donepezil Hcl	47	13
Diclofenac Sodium	Diclofenac Sodium	45	21
Methocarbamol	Methocarbamol	45	20
Mirtazapine	Mirtazapine	45	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	15
Trulicity	Dulaglutide	42	12
Famotidine	Famotidine	41	18
Fluconazole	Fluconazole	41	27
Celecoxib	Celecoxib	40	14
Diazepam	Diazepam	40	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	40	21
Pregabalin	Pregabalin	39	13
Ondansetron Hcl	Ondansetron Hcl	35	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	13
Glipizide Er	Glipizide	32	12
Buspirone Hcl	Buspirone Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	13
Prednisone	Prednisone	30	19
Amoxicillin	Amoxicillin	28	17
Bupropion Xl	Bupropion Hcl	28	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	23
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Estradiol	Estradiol	26	18
Ezetimibe	Ezetimibe	25	11
Irbesartan	Irbesartan	25	suppressed
Nystatin	Nystatin	25	15
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	22	suppressed
Lidocaine	Lidocaine	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Clindamycin Hcl	Clindamycin Hcl	21	12
Finasteride	Finasteride	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Testosterone	Testosterone	20	suppressed
Baclofen	Baclofen	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Ketoconazole	Ketoconazole	18	suppressed
Ondansetron Odt	Ondansetron	18	12
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Colchicine	Colchicine	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Cephalexin	Cephalexin	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methylprednisolone	Methylprednisolone	14	13
Metronidazole	Metronidazole	14	suppressed
Mupirocin	Mupirocin	14	12
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Dayvigo	Lemborexant	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Naproxen	Naproxen	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Glipizide	Glipizide	12	suppressed
Ramipril	Ramipril	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Primidone	Primidone	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error